EUVIMEDEUVIMED entdecken
Crossref

The third case of Marbach‐Rustad progeroid syndrome caused by a de novo LEMD2 variant

Zhikun Lu, Wen Zhang, Xiaojian Mao, Duan Li, Xiaodan Chen, Li Liu iD, Yunting Lin iD

Clinical Genetics · 2024-02 · 105 (2) · 209-213

DOI: 10.1111/cge.14441 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Genetics, online erschienen am 23.10.2023. Verfasst von Zhikun Lu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics and Endocrinology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangdong Provincial Clinical …. Hauptthemen laut MEDLINE: Membrane Proteins, Nuclear Proteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Marbach‐Rustad progeroid syndrome is an extremely rare disease caused by a heterozygous variant in the LEMD2 gene. To date, only two patients and one LEMD2 pathogenic variant have been reported in Marbach‐Rustad progeroid syndrome. Here we describe the third case of Marbach‐Rustad progeroid syndrome worldwide, which is also the first case in China. The proband was affected with premature birth, failed to thrive, facial abnormalities, feeding difficulties, skull defects and delayed motor milestones, but had a normal intelligence and speech. Whole exome sequencing (WES) initially did not find a phenotype‐causing variant when the proband was 1 year of age. The reanalysis of WES data 4 years later revealed the proband harbored a de novo heterozygous c.1436C>T(p.Ser479Phe) variant in the LEMD2 gene, which is known responsible for Marbach‐Rustad progeroid syndrome. Sanger sequencing confirmed the presence of this variant in the proband and absence in his parents and two elder sisters. Our study provides accurate clinical diagnosis for the proband and adds a new patient with Marbach‐Rustad progeroid syndrome. Our study suggests the LEMD2 c.1436C>T(p.Ser479Phe) variant as a hotspot. Our work also indicates reanalysis of WES data of negative cases might identify pathogenic variant and improve diagnostic efficiency.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Membrane ProteinsNuclear ProteinsHumansChinaExome SequencingHeterozygoteMutationPhenotypeFemaleInfant

Stichwörter der Autor:innen

LEMD2 geneMarbach-Rustad progeroid syndromeSanger sequencingwhole exome sequencing

Substanzen

LEMD2 protein, humanMembrane ProteinsNuclear Proteins

Autor:innen und Institutionen

  • Department of Genetics and Endocrinology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangdong Provincial Clinical Research Center for Child Health, Guangzhou, China.

ORCID-Profile: Li Liu, Yunting Lin

Zitieren

APA

Lu, Z., Zhang, W., Mao, X., Li, D., Chen, X., Liu, L., & Lin, Y. (2024). The third case of Marbach‐Rustad progeroid syndrome caused by a de novo LEMD2 variant. Clinical Genetics, 105(2), 209-213. https://doi.org/10.1111/cge.14441

Vancouver

Lu Z, Zhang W, Mao X, Li D, Chen X, Liu L, et al. The third case of Marbach‐Rustad progeroid syndrome caused by a de novo LEMD2 variant. Clinical Genetics. 2024;105(2):209-213. doi:10.1111/cge.14441

BibTeX
@article{Lu2024,
  author = {Lu, Zhikun and Zhang, Wen and Mao, Xiaojian and Li, Duan and Chen, Xiaodan and Liu, Li and Lin, Yunting},
  title = {The third case of Marbach‐Rustad progeroid syndrome caused by a de novo LEMD2 variant},
  journal = {Clinical Genetics},
  year = {2024},
  volume = {105},
  number = {2},
  pages = {209--213},
  doi = {10.1111/cge.14441}
}
Kostenlos starten →